Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
about
Metabolic syndrome in rheumatoid arthritisEffects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-AnalysisThe Obesity Epidemic and Consequences for Rheumatoid Arthritis CareAssociation between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patientsAbnormal Glucose Metabolism in Rheumatoid ArthritisInsulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediatorAdipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis.Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women.Reversing vascular dysfunction in rheumatoid arthritis: improved augmentation index but not endothelial function with peroxisome proliferator-activated receptor γ agonist therapy.Adipose depots, not disease-related factors, account for skeletal muscle insulin sensitivity in established and treated rheumatoid arthritisRisk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasisChanges in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases.Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatmentThe value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effectsSignificant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis.Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis.Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis.Pulse Wave Velocity, Intima Media Thickness, and Flow-mediated Dilatation in Patients with Normotensive Normoglycemic Inflammatory Bowel Disease.Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study.Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis.Increased prevalence of subclinical atherosclerosis in rheumatoid arthritis patients of Indian descent.Overweight Is a Major Contributor to Atherosclerosis in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease: A Cross-Sectional Controlled Study.Increased toll-like receptor 2 expression in peptidoglycan-treated blood monocytes is associated with insulin resistance in patients with nondiabetic rheumatoid arthritis.Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritisTraditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis.Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects?Impaired beta cell function is present in nondiabetic rheumatoid arthritis patientsFree fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosusInfluence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis.Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus.Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis.Immune mechanisms in atherosclerosis, especially in diabetes type 2Inflammation and hypertension in rheumatoid arthritisDrugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors.Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases.Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury.Premature vascular damage in systemic lupus erythematosus.Does a lack of physical activity explain the rheumatoid arthritis lipid profile?
P2860
Q26822038-A6791CB7-D185-4EAE-AF10-080029CD7844Q26825588-2847A114-E1C0-40ED-A7F6-9E472C56F732Q28074864-DC35E4C1-65E5-4EE1-B360-0011C0C5B9BBQ33650548-76D10A3A-3513-44CF-BB2E-F01079CCF197Q33654451-DB5DD07C-E903-4EB0-A7E9-4575A4A72003Q33671233-BD3B93AE-E176-48E1-BE0E-0CAD443E69E3Q34021686-E24D9513-71A0-45A9-A007-FFDF0D8AF1CCQ34056227-622C2200-2B5C-4999-9ADF-26F1B8D36AF5Q34098318-E9581A86-E0C1-43F6-8156-49FA3ACFCF12Q34287829-BB0F802C-4BEE-41CE-8D7C-229DA543F0BEQ34348857-A427B550-3812-4A9D-B490-DF0DADD72C75Q34354276-FB4541F9-B1C5-4F74-8F6B-92A381AB0630Q34486477-9AE9F0D9-FD13-42EF-9754-55D08089D56FQ34563216-A1AC7855-9AAB-4C12-871A-F3AA7C29DB41Q34597321-ECDE0316-1466-41BF-BFE4-45A1A92BE7ECQ35257568-B729D410-EDDB-4087-BD2E-B1DB914973A2Q35581083-F10039E0-3024-48A4-96C0-CF0C01BB22EFQ35596467-F9438C79-9F02-4BD8-A434-AFACAD30B76EQ35670684-8FD8777B-60D7-4536-80B5-8B919AF5BE66Q35840769-47221A6C-593C-42BB-ADFC-A0F69C0BF1DAQ35921093-22993848-5BB4-4C6D-AA77-40264E668483Q36058974-77EE2A35-068A-4880-B6AF-656518A197E8Q36359128-AA106210-9AC3-40EC-8FD9-840BCCEE95E4Q36429729-FD1909DB-D054-4422-8378-6753AE6C69FDQ36456346-9F16C595-D225-486C-A267-C88D76B924C9Q36464352-2925DA4B-6730-492A-B8FD-CCB412BBB4A0Q36705720-FBC05FA0-F5B9-4356-B168-095981CAC1F4Q36903389-58B53B23-165E-4FB8-9B19-C0D6F1E30D40Q36934234-75FCA963-2480-4E3A-A8C6-9C3F637339AEQ37000208-F6FE8D9D-2764-4613-B688-3B7A74EE978AQ37058791-14AA4BB3-A54F-4485-83AF-5B490330615EQ37174146-66D59258-3D90-49C4-998F-1037E488A298Q37179297-89128A1A-E064-4B70-B9BE-5E5B599CB345Q37261617-36C7DE13-9D52-4992-A530-7C1335408051Q37281848-3880A28B-5982-41E2-B8CB-EDEAACD1DBF8Q37292191-DD4748F6-8980-4221-8FCC-B1BA30F56F1AQ37385755-F56CDC57-31C8-4F1B-8608-E9F7B515B01EQ37436638-673BF013-7C7D-46F3-85DB-11B6A8D1AFE4Q37573524-6807CB88-328A-4377-960D-A6B2F0B60391Q37637193-22CDD113-5C42-4DB5-B2FC-C2B007C72F78
P2860
Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammation-associated insuli ...... s define potential mechanisms.
@en
Inflammation-associated insuli ...... s define potential mechanisms.
@nl
type
label
Inflammation-associated insuli ...... s define potential mechanisms.
@en
Inflammation-associated insuli ...... s define potential mechanisms.
@nl
prefLabel
Inflammation-associated insuli ...... s define potential mechanisms.
@en
Inflammation-associated insuli ...... s define potential mechanisms.
@nl
P2093
P2860
P356
P1476
Inflammation-associated insuli ...... s define potential mechanisms.
@en
P2093
Annette Oeser
Ayumi Shintani
C Michael Stein
Cecilia P Chung
Ingrid Avalos
Joseph F Solus
Paolo Raggi
Tuulikki Sokka
P2860
P304
P356
10.1002/ART.23600
P577
2008-07-01T00:00:00Z